We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.

The next Alzheimer’s treatment could come from an unexpected place. In new research released this week, scientists have found ...

Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...

European Union regulators will review new information relating to the safety of Eisai Co.’s and Biogen Inc.’s medicine for ...

New research suggests that commonly used medications like antibiotics, antivirals, and anti-inflammatories could lower the ...

A new blood test is being trialed in the UK to detect the early signs of dementia. It is hoped it could identify patients ...

The geroscience hypothesis focuses on extending the healthy lifespan by targeting aging mechanisms. Recent advances in ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for ...